Background:
Pulmonary endothelial damage has been shown to precede the development of emphysema in animals, and vascular changes in humans have been observed in COPD and emphysema.
Research Question:
Is intraparenchymal vascular pruning associated with longitudinal progression of emphysema on CT imaging or decline in lung function over 5 years?
Study Design And Methods:
The Genetic Epidemiology of COPD Study enrolled ever smokers with and without COPD from 2008 through 2011. The percentage of emphysema-like lung, or "percent emphysema," was assessed at baseline and after 5 years on noncontrast CT imaging as the percentage of lung voxels < -950 Hounsfield units. An automated CT imaging-based tool assessed and classified intrapulmonary arteries and veins. Spirometry measures are postbronchodilator. Pulmonary arterial pruning was defined as a lower ratio of small artery volume (< 5 mm cross-sectional area) to total lung artery volume. Mixed linear models included demographics, anthropomorphics, smoking, and COPD, with emphysema models also adjusting for CT imaging scanner and lung function models adjusting for clinical center and baseline percent emphysema.
Results:
At baseline, the 4,227 participants were 60 ± 9 years of age, 50% were women, 28% were Black, 47% were current smokers, and 41% had COPD. Median percent emphysema was 2.1 (interquartile range, 0.6-6.3) and progressed 0.24 percentage points/y (95% CI, 0.22-0.26 percentage points/y) over 5.6 years. Mean FEV to FVC ratio was 68.5 ± 14.2% and declined 0.26%/y (95% CI, -0.30 to -0.23%/y). Greater pulmonary arterial pruning was associated with more rapid progression of percent emphysema (0.11 percentage points/y per 1-SD increase in arterial pruning; 95% CI, 0.09-0.16 percentage points/y), including after adjusting for baseline percent emphysema and FEV. Arterial pruning also was associated with a faster decline in FEV to FVC ratio (-0.04%/y per 1-SD increase in arterial pruning; 95% CI, -0.008 to -0.001%/y).
Interpretation:
Pulmonary arterial pruning was associated with faster progression of percent emphysema and more rapid decline in FEV to FVC ratio over 5 years in ever smokers, suggesting that pulmonary vascular differences may be relevant in disease progression.
Trial Registry:
ClinicalTrials.gov; No.: NCT00608764; URL: www.clinicaltrials.gov.
Citing Articles
Quantitative assessment of lung structure changes in low-intensity smokers: a retrospective study in a Chinese male cohort.
Shen R, Guo Y, Shen C
Quant Imaging Med Surg. 2025; 15(1):287-298.
PMID: 39838995
PMC: 11744156.
DOI: 10.21037/qims-24-1171.
Chest Computed Tomography to Improve Phenotyping in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
Johnson S, Wan E, San Jose Estepar R, Nardelli P, Pistenmaa C, Piccari L
Ann Am Thorac Soc. 2024; 22(2):175-180.
PMID: 39556097
PMC: 11808541.
DOI: 10.1513/AnnalsATS.202408-878PS.
Higher small pulmonary artery and vein volume on computed tomography is associated with mortality in current and former smokers.
Kwee A, Andrinopoulou E, van der Veer T, Gallardo-Estrella L, Charbonnier J, Humphries S
EBioMedicine. 2024; 108:105366.
PMID: 39353280
PMC: 11464249.
DOI: 10.1016/j.ebiom.2024.105366.
Computed tomography (CT) quantitative assessment of single lobe emphysema correlates with chronic obstructive pulmonary disease (COPD) severity: a cross-sectional study with retrospective data collection.
Li W, Meng H, Huang S, Lin H, Chen H
Quant Imaging Med Surg. 2024; 14(7):4540-4554.
PMID: 39022233
PMC: 11250351.
DOI: 10.21037/qims-23-1496.
Abnormal heart rate responses to exercise in non-severe COPD: relationship with pulmonary vascular volume and ventilatory efficiency.
Shi M, Qumu S, Wang S, Peng Y, Yang L, Huang K
BMC Pulm Med. 2024; 24(1):183.
PMID: 38632576
PMC: 11022473.
DOI: 10.1186/s12890-024-03003-y.
Vessel and Airway Characteristics in One-Year Computed Tomography-defined Rapid Emphysema Progression: SPIROMICS.
Gerard S, Dougherty T, Nagpal P, Jin D, Han M, Newell Jr J
Ann Am Thorac Soc. 2024; 21(7):1022-1033.
PMID: 38530051
PMC: 11284327.
DOI: 10.1513/AnnalsATS.202304-383OC.
Peripheral Blood Mononuclear Cell Gene Expression Associated with Pulmonary Microvascular Perfusion: The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease.
Buschur K, Pottinger T, Vogel-Claussen J, Powell C, Aguet F, Allen N
Ann Am Thorac Soc. 2024; 21(6):884-894.
PMID: 38335160
PMC: 11160125.
DOI: 10.1513/AnnalsATS.202305-417OC.
Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry.
Ritchie A, Donaldson G, Hoffman E, Allinson J, Bloom C, Bolton C
Am J Respir Crit Care Med. 2024; 209(10):1208-1218.
PMID: 38175920
PMC: 11146542.
DOI: 10.1164/rccm.202307-1203OC.
Pulmonary Vasodilator Therapy in Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (Severe PH-COPD): A Systematic Review and Meta-Analysis.
Elkhapery A, Hammami M, Sulica R, Boppana H, Abdalla Z, Iyer C
J Cardiovasc Dev Dis. 2023; 10(12).
PMID: 38132665
PMC: 10743410.
DOI: 10.3390/jcdd10120498.
Quantitative Analysis for Lung Disease on Thin-Section CT.
Iwasawa T, Matsushita S, Hirayama M, Baba T, Ogura T
Diagnostics (Basel). 2023; 13(18).
PMID: 37761355
PMC: 10528918.
DOI: 10.3390/diagnostics13182988.
Quantitative Imaging Metrics for the Assessment of Pulmonary Pathophysiology: An Official American Thoracic Society and Fleischner Society Joint Workshop Report.
Hsia C, Bates J, Driehuys B, Fain S, Goldin J, Hoffman E
Ann Am Thorac Soc. 2023; 20(2):161-195.
PMID: 36723475
PMC: 9989862.
DOI: 10.1513/AnnalsATS.202211-915ST.
Endotyping COPD: hypoxia-inducible factor-2 as a molecular "switch" between the vascular and airway phenotypes?.
Myronenko O, Foris V, Crnkovic S, Olschewski A, Rocha S, Nicolls M
Eur Respir Rev. 2023; 32(167).
PMID: 36631133
PMC: 9879331.
DOI: 10.1183/16000617.0173-2022.
Contributions of Emphysema and Functional Small Airway Disease on Intrapulmonary Vascular Volume in COPD.
Huang X, Yin W, Shen M, Wang X, Ren T, Wang L
Int J Chron Obstruct Pulmon Dis. 2022; 17:1951-1961.
PMID: 36045693
PMC: 9423118.
DOI: 10.2147/COPD.S368974.
Journal Club: Impaired Ventilatory Efficiency and Exercise Intolerance in Former/Current Smokers With Dyspnea Disproportionate to Their Lung Function: Pathophysiological Insights Gained Through Cardiopulmonary Exercise Testing.
Balkissoon R, Mkorombindo T
Chronic Obstr Pulm Dis. 2022; 9(3):477-485.
PMID: 35905756
PMC: 9448006.
DOI: 10.15326/jcopdf.2022.0344.
Origins of and lessons from quantitative functional X-ray computed tomography of the lung.
Hoffman E
Br J Radiol. 2022; 95(1132):20211364.
PMID: 35193364
PMC: 9153696.
DOI: 10.1259/bjr.20211364.